DRD2 rs4648317: What Your Genotype Means
The rs4648317 variant is a single nucleotide polymorphism located within the DRD2 gene, which encodes a critical dopamine receptor. While it has been investigated for potential links to reproductive health conditions like endometriosis-related infertility and various behavioral traits, current evidence remains mixed or inconclusive.
What each genotype means
Typical dopamine receptor profile
This genotype is considered the baseline or normal state for this variant in the DRD2 gene. Research has not identified specific clinical risks or behavioral associations linked to this combination of alleles.
This is a common genotype found in the general population.
Potential nicotine dependence association
Some research suggests that individuals with this genotype may be more prone to higher nicotine dependence. However, evidence is limited and associations with behavioral traits like sensation seeking remain preliminary.
This genotype is observed frequently across diverse global populations.
Increased sensation seeking association
Studies have suggested that this genotype may be associated with higher nicotine dependence and increased tendencies toward impulsive or sensation-seeking behaviors. These findings are based on limited observational data and should not be used to predict individual behavior or health outcomes.
This is a common genotype, though its specific frequency varies by ancestral background.
Understanding the rs4648317 Variant
The rs4648317 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located on chromosome 11 within the DRD2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant sits within a linkage disequilibrium block of the DRD2 gene, meaning it is often inherited alongside other nearby genetic markers. Because it is located in a region that influences how the gene is regulated or expressed, researchers have long been interested in whether this specific change alters the function of the dopamine D2 receptor. Understanding the location of this SNP is essential for researchers studying how subtle variations in our genetic code might contribute to complex biological processes, ranging from neurological signaling to reproductive health.
The Role of the DRD2 Gene
The DRD2 gene provides instructions for creating the D2 dopamine receptor, a protein found primarily in the brain and the pituitary gland. Dopamine is a neurotransmitter that acts as a chemical messenger, helping to regulate movement, motivation, reward, and various hormonal processes. By binding to the D2 receptor, dopamine helps modulate the activity of cells, effectively acting as a 'brake' or 'accelerator' for different physiological signals. In the pituitary gland, for instance, the D2 receptor plays a key role in regulating the secretion of prolactin, a hormone involved in reproductive functions. Because the DRD2 gene is so central to these diverse systems, scientists frequently study its variants to see if they correlate with differences in how individuals respond to dopamine or how their bodies manage hormonal balance.
Research and Evidence Strength
The evidence linking rs4648317 to specific health outcomes is considered moderate and often conflicting. Historically, researchers investigated this SNP to see if it contributed to endometriosis-related infertility, hypothesizing that altered dopamine signaling might affect prolactin levels and reproductive success. However, studies, such as those published in Molecular Medicine Reports, have found no significant differences in genotype frequencies between women with endometriosis-related infertility and control groups, suggesting it may not be a primary risk factor for this condition. Other research has explored potential associations with behavioral traits, such as nicotine dependence or sensation-seeking, with some studies suggesting a possible link to higher dependence scores. It is important to note that these associations are statistical in nature and do not imply a direct cause-and-effect relationship. Given the mixed results across different studies, the clinical significance of this variant remains a subject of ongoing scientific inquiry rather than a settled medical fact.
Population Frequency
The rs4648317 variant is considered a common SNP across various human populations. Genetic databases, such as those tracking global allele frequencies, indicate that both the C and T alleles are present at significant frequencies in many ancestral groups. Because it is common, most individuals will carry at least one copy of the variant, and it is not considered a rare mutation. The distribution of these genotypes can vary slightly depending on the specific population being studied, but it is generally widespread. This high frequency is typical for many SNPs in the DRD2 gene, which have been maintained in the human gene pool over time. Understanding that this is a common variant helps contextualize research findings, as it suggests that any potential effects are likely subtle and influenced by a wide range of other genetic and environmental factors.
Interpreting Your Genetic Information
If you have received information about your rs4648317 genotype, it is important to view it within the context of current scientific uncertainty. Because the evidence linking this variant to specific health outcomes is mixed or inconclusive, this information should not be used to make medical decisions or to predict personal health outcomes. Genetic variants rarely act in isolation; they interact with your environment, lifestyle, and thousands of other genes to shape your health. If you are concerned about reproductive health, behavioral patterns, or any other condition, please consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your results in the context of your overall health history and provide guidance based on established clinical standards rather than preliminary research findings.
How common is this variant?
The rs4648317 variant is common across global populations, with a minor allele frequency typically reported around 23-24% in many datasets.
Frequently asked questions
Is rs4648317 a cause of endometriosis?
Current research, including studies specifically examining this SNP, has not found a significant association between rs4648317 and endometriosis-related infertility. The evidence does not support using this variant as a diagnostic or risk factor for the condition.
Does my genotype for rs4648317 mean I will have nicotine dependence?
No. While some studies have explored statistical links between this variant and nicotine dependence, these findings are not definitive. Genetic markers are only one small part of a complex set of factors that influence behavior and addiction.
Should I change my medication based on this SNP?
You should never change your medication or dosage based on a single genetic variant. Always discuss your medications and any concerns about your genetic profile with your prescribing physician or a pharmacist.
Where can I find more information about DRD2 variants?
You can explore resources like the GWAS Catalog or PubMed for peer-reviewed research on DRD2. For clinical information, consult your doctor or a certified genetic counselor who can provide context for your specific health situation.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4648317?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This dopamine receptor D2 variant was investigated as a potential genetic risk factor for endometriosis-related infertility.
Commonly studied variant in the Dopamine D2 Receptor gene linked to cognitive flexibility and processing speed.
Also known as TaqIB, this dopamine receptor D2 intronic variant is associated with reward processing, cognitive flexibility, and sensory preference traits.
This SNP in the dopamine receptor D2 gene was investigated as a potential genetic risk factor for endometriosis-related infertility.
This variant in the dopamine receptor D2 gene has shown suggestive association with polysomnographically determined sleep latency.
The DRD2 TaqIB variant modulates dopamine D2 receptor density and has been widely investigated for associations with addiction susceptibility and therapeutic response to antipsychotics.